These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 144056)

  • 41. Chronic hepatitis B infection and autoimmune thyroiditis in Down syndrome.
    May P; Kawanishi H
    J Clin Gastroenterol; 1996 Oct; 23(3):181-4. PubMed ID: 8899498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Normal immune response to hepatitis B vaccine in patients with Down's syndrome. A basis for immunization guidelines.
    Troisi CL; Heiberg DA; Hollinger FB
    JAMA; 1985 Dec; 254(22):3196-9. PubMed ID: 2933533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
    Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
    Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.
    Alward WL; McMahon BJ; Hall DB; Heyward WL; Francis DP; Bender TR
    J Infect Dis; 1985 Apr; 151(4):604-9. PubMed ID: 2982971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages.
    Burgio GR; Ugazio AG; Nespoli L; Marcioni AF; Bottelli AM; Pasquali F
    Eur J Immunol; 1975 Sep; 5(9):600-3. PubMed ID: 11993318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thyroid antibodies in relation to infectious hepatitis and Down's syndrome.
    Dallaire L; Kingsmill-Flynn D; Leboeuf G
    J Ment Defic Res; 1968 Jun; 12(2):93-9. PubMed ID: 4232892
    [No Abstract]   [Full Text] [Related]  

  • 48. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded.
    Tevaluoto-Aarnio M; Werner B; London WT
    Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunology of Down syndrome: a review.
    Ugazio AG; Maccario R; Notarangelo LD; Burgio GR
    Am J Med Genet Suppl; 1990; 7():204-12. PubMed ID: 2149949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Occurrence of hepatitis B surface antigen in patients with Down's syndrome.
    Yüksel M; Uzunalimoğlu O; Oge G; Demirağ B
    Turk J Pediatr; 1977; 19(1-2):47-51. PubMed ID: 154756
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: a prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection.
    Furusyo N; Hayashi J; Sawayama Y; Kishihara Y; Kashiwagi S
    Am J Trop Med Hyg; 1999 Apr; 60(4):616-22. PubMed ID: 10348237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Down's syndrome and autoimmunity.
    Levo Y; Green P
    Am J Med Sci; 1977; 273(1):95-9. PubMed ID: 139824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alopecia areata, autoimmunity, and Down's syndrome.
    Du Vivier A; Munro DD
    Br Med J; 1975 Jan; 1(5951):191-2. PubMed ID: 122906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine].
    García O; Bruguera M; Mayor A; Sánchez-Tapias JM; Vall O; Rodés J
    Enferm Infecc Microbiol Clin; 1990 Mar; 8(3):148-52. PubMed ID: 2151250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Australia antigen and Down's syndrome.
    Dallapiccola B
    Lancet; 1971 Sep; 2(7723):548. PubMed ID: 4105695
    [No Abstract]   [Full Text] [Related]  

  • 57. [Celiac disease in children with Down's syndrome].
    Lazzari R; Collina A; Arena G; Corvaglia L; Marzatico M; Vallini M; Bochicchio A; Pasetti A; Frassineti S; Forchielli L
    Pediatr Med Chir; 1994; 16(5):467-70. PubMed ID: 7885956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Characteristics and Correlation Analysis of Subjects with Chronic Hepatitis B Virus (HBV) Infection and Sustained Low Levels of Hepatitis B Surface Antigen (HBsAg).
    Cheng J; Dai Y; Yan L; Zhou H; Xu X; Sun C; Wang Z
    Med Sci Monit; 2018 Mar; 24():1826-1835. PubMed ID: 29593208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Periodontal conditions in individuals with Down's syndrome.
    Bagić I; Verzak Z; Cuković-Cavka S; Brkić H; Susić M
    Coll Antropol; 2003; 27 Suppl 2():75-82. PubMed ID: 12971174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.